Diamond Biofund Inc. (TPE: 6901)
Taiwan
· Delayed Price · Currency is TWD
31.10
+0.45 (1.47%)
Jan 20, 2025, 1:30 PM CST
Diamond Biofund Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 17.07 | 2,103 | 333.84 | 18.14 | 28.52 | 416.14 |
Short-Term Investments | - | - | - | 4.5 | 119.34 | 4.5 |
Trading Asset Securities | 5,982 | 7,544 | 10,404 | 10,065 | 6,519 | 838.51 |
Cash & Short-Term Investments | 5,999 | 9,647 | 10,738 | 10,087 | 6,667 | 1,259 |
Cash Growth | -49.70% | -10.16% | 6.45% | 51.30% | 429.49% | - |
Accounts Receivable | - | - | 1.87 | 1.69 | 1.86 | 9.82 |
Other Receivables | 2.21 | 2.64 | 0.21 | - | 0.12 | 0.13 |
Receivables | 2.21 | 2.64 | 2.08 | 1.69 | 1.98 | 9.95 |
Other Current Assets | 1.5 | 6 | 0.59 | 0.08 | 0.08 | 1.87 |
Total Current Assets | 6,003 | 9,656 | 10,741 | 10,089 | 6,669 | 1,271 |
Property, Plant & Equipment | 142.26 | 124.81 | 5.7 | 43.87 | 55.63 | 67.25 |
Long-Term Investments | 5,158 | 3,235 | 445.28 | 406.09 | 2,530 | 1,738 |
Other Intangible Assets | 0.23 | 0.14 | 0.28 | - | - | - |
Other Long-Term Assets | 9.04 | 25.77 | 2.59 | 83.68 | 2.69 | 2.81 |
Total Assets | 11,313 | 13,042 | 11,194 | 10,623 | 9,257 | 3,079 |
Current Portion of Leases | 23.72 | 15.23 | 3.67 | 8.73 | 7.7 | 9.14 |
Current Income Taxes Payable | - | - | 83.26 | 105.58 | 1.69 | - |
Other Current Liabilities | 62.13 | 50.73 | 57.13 | 83.24 | 104.51 | 7.2 |
Total Current Liabilities | 85.85 | 65.96 | 144.06 | 197.55 | 113.9 | 16.34 |
Long-Term Leases | 99.98 | 113.78 | - | 33.26 | 42.91 | 52.34 |
Total Liabilities | 185.83 | 179.74 | 144.06 | 230.82 | 156.81 | 68.67 |
Common Stock | 8,505 | 8,499 | 6,350 | 5,000 | 4,500 | 4,500 |
Additional Paid-In Capital | 3,542 | 3,530 | 12.75 | 1.16 | - | - |
Retained Earnings | -919.42 | 833.05 | 4,688 | 5,391 | 4,600 | -1,489 |
Shareholders' Equity | 11,127 | 12,862 | 11,050 | 10,392 | 9,100 | 3,011 |
Total Liabilities & Equity | 11,313 | 13,042 | 11,194 | 10,623 | 9,257 | 3,079 |
Total Debt | 123.7 | 129.01 | 3.67 | 41.99 | 50.61 | 61.47 |
Net Cash (Debt) | 5,876 | 9,518 | 10,734 | 10,045 | 6,616 | 1,198 |
Net Cash Growth | -50.74% | -11.33% | 6.86% | 51.82% | 452.44% | - |
Net Cash Per Share | 6.91 | 12.22 | 13.95 | 10.52 | 9.66 | 1.78 |
Filing Date Shares Outstanding | 850.47 | 849.89 | 749.3 | 914.2 | 749.3 | 674.37 |
Total Common Shares Outstanding | 850.47 | 849.89 | 749.3 | 914.2 | 674.37 | 674.37 |
Working Capital | 5,917 | 9,590 | 10,597 | 9,892 | 6,555 | 1,255 |
Book Value Per Share | 13.08 | 15.13 | 14.75 | 11.37 | 13.49 | 4.46 |
Tangible Book Value | 11,127 | 12,862 | 11,050 | 10,392 | 9,100 | 3,011 |
Tangible Book Value Per Share | 13.08 | 15.13 | 14.75 | 11.37 | 13.49 | 4.46 |
Source: S&P Capital IQ. Standard template. Financial Sources.